Clincosm LogoSign in Get a demo

esophagogastric cancer

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophagogastric Cancer Trial in Toronto (PET-MRI)

Recruiting
  • Esophagogastric Cancer
  • PET-MRI
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 5, 2023

Esophagogastric Cancer Trial in New York (Survey, Intra-oral camera)

Recruiting
  • Esophagogastric Cancer
  • Survey
  • Intra-oral camera
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Dec 28, 2022

Esophagogastric Cancer, HER2-Negative Trial in United States (regorafenib, nivolumab, FOLFOX chemo with oxaliplatin)

Active, not recruiting
  • Esophagogastric Cancer
  • HER2-Negative
  • Basking Ridge, New Jersey
  • +6 more
Nov 23, 2022

NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +10 more
  • Singapore, Singapore
    Novartis Investigative Site
Nov 16, 2022

Esophagogastric Cancer, Moderate to Severe Dysphagia Trial in New York, Re?ovot (WST 11-mediated VTP therapy)

Active, not recruiting
  • Esophagogastric Cancer
  • Moderate to Severe Dysphagia
  • WST 11-mediated VTP therapy
  • New York, New York
  • +1 more
Oct 25, 2022

Esophagogastric Cancer Trial in United States (Amivantamab)

Recruiting
  • Esophagogastric Cancer
  • Boston, Massachusetts
  • +7 more
Oct 24, 2022

Esophagogastric Cancer Trial in New York (89Zr-DFO-trastuzumab, PET imaging)

Active, not recruiting
  • Esophagogastric Cancer
  • 89Zr-DFO-trastuzumab
  • PET imaging
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 7, 2021

Gastroesophageal Junction Adenocarcinoma, Esophagogastric Cancer Trial in Boston, Newton (FOLFOX/ nal-IRI, Paclitaxel,

Not yet recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • Esophagogastric Cancer
  • FOLFOX/ nal-IRI
  • +3 more
  • Boston, Massachusetts
  • +2 more
Nov 30, 2020

Esophagogastric Cancer Trial in Boston (STA-9090)

Completed
  • Esophagogastric Cancer
  • Boston, Massachusetts
  • +2 more
Jul 31, 2020

Pancreatic Cancer, NSCLC, Esophagogastric Cancer Trial in United States (Andecaliximab, Gemcitabine, Nab-paclitaxel)

Completed
Has Results
  • Pancreatic Cancer
  • +4 more
  • Birmingham, Alabama
  • +17 more
May 20, 2020

Esophagogastric Cancer Trial (Pemetrexed, Oxaliplatin, Leucovorin)

Withdrawn
  • Esophagogastric Cancer
  • (no location specified)
Mar 7, 2016